logo-cropped

NovaDigm Therapeutics Strengthens Candida Vaccine Portfolio with Three New Antigens via Series of Rights Acquisitions

Monday, 09 June 2014 03:00
GRAND FORKS, N.D.--(BUSINESS WIRE)-- NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced that it has acquired the rights, in four separate transactions, to three well-studied Candida vaccine antigens, significantly bolstering the Company’s Candida vaccine pipeline. These three antigens are in addition to the Company’s agglutinin-like sequence 3 (Als3) antigen used in NDV-3, NovaDigm’s lead vaccine being evaluated in an on-going Phase 1b/2a study.
Shawn Vincent Ph.D. Launches New Health Care Consulting Firm
Tuesday, 03 June 2014 21:53
New Orleans, Louisiana (PRWEB) June 05, 2014 After a successful career as an independent consultant and analyst in the health care sector, Shawn Vincent is partnering with regional experts to form a new health care consulting firm. The firm will be based primarily in the Philippines, but will have satellite offices in New Orleans and Hong Kong.
Ebola Vaccine Is Safe And Can Produce Strong Immune Response In Chimpanzees: Study
Monday, 26 May 2014 04:20
University of Cambridge The first conservation-specific vaccine trial on captive chimpanzees has proved a vaccine against Ebola virus is both safe and capable of producing a robust immune response in chimpanzees. This unprecedented study, published in the journal PNAS, shows that ‘orphan’ vaccines – which never complete the expensive licensing process for human use – can be co-opted for use on wildlife and might be a godsend for highly endangered species such as gorillas and…
Cambridge proves vaccine works on endangered apes
Monday, 26 May 2014 03:14
Orphan vaccines denied use in humans could save endangered apes such as chimpanzees and gorillas, a University of Cambridge research chief believes. Dr Peter Walsh has drawn hope from the first conservation-specific vaccine trial on captive chimpanzees which proved that a vaccine against Ebola virus is both safe and capable of producing a robust immune response in chimpanzees.
Indications: U.S. stock futures climb after durable-goods orders
Monday, 26 May 2014 00:30
By Sara Sjolin and Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) — U.S. stock futures pointed to a higher open on Tuesday, as investors welcomed a surprise rise in durable-goods orders, driven by demand for military hardware and better-than-expected housing data. Futures for the Dow Jones Industrial Average /quotes/zigman/17775921/realtimeDJM4+0.38% rose 67 points, or 0.4%, to 16,653, while those for the S&P 500 index /quotes/zigman/10359611/realtimeSPM4+0.41% gained 8.10 points, or 0.4%, to 1,905.
Indications: U.S. stock futures climb after upbeat data
Monday, 26 May 2014 00:30
By Sara Sjolin and Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) — U.S. stock futures pointed to a higher open on Tuesday, as investors welcomed a surprise rise in durable-goods orders, driven by demand for military hardware and better-than-expected housing data. Futures for the Dow Jones Industrial Average /quotes/zigman/17775921/realtimeDJM4+0.38% rose 67 points, or 0.4%, to 16,653, while those for the S&P 500 index /quotes/zigman/10359611/realtimeSPM4+0.41% gained 8.10 points, or 0.4%, to 1,905.
Ebola vaccine success highlights dilemma of testing on captive chimps to save wild apes
Sunday, 25 May 2014 09:23
PUBLIC RELEASE DATE: 26-May-2014[ | E-mail ] ShareContact: Fred Lewsey This email address is being protected from spambots. You need JavaScript enabled to view it. 44-122-376-5566 University of Cambridge The first conservation-specific vaccine trial on captive chimpanzees has proved a vaccine against Ebola virus is both safe and capable of producing a robust immune response in chimpanzees.
Biotech Factories to Farm Fake Meat
Monday, 19 May 2014 07:06
RelatedLinks First Lab-Grown Burger To Be Served DNews: Food Label Lies! Eating in an Emergency: Photos The movement to sell locally sourced, artisanal food and drink has picked up steam in recent years as many consumers demand better quality products with a smaller environmental footprint and traceable pedigree.
2014 BIO World Congress: Outlook on Policy Affecting Advanced Biofuels and Renewable Chemicals
Thursday, 15 May 2014 10:15
The 2014 BIO World Congress on Industrial Biotechnology kicked off with a much needed policy discussion on the issues facing the industrial biotechnology industry. The exclusive Pre-conference Workshop was called “U.S. Policy Outlook: From the RFS to Tax Reform to Farm Bill Implementation – What Lies Ahead for Advance Biofuels and Renewable Chemicals?”.
2014 BIO World Congress: Policy Affecting Advanced Biofuels & Renewable Chemicals
Thursday, 15 May 2014 10:15
The 2014 BIO World Congress on Industrial Biotechnology kicked off with a much needed policy discussion on the issues facing the industrial biotechnology industry. The exclusive Pre-conference Workshop was called “U.S. Policy Outlook: From the RFS to Tax Reform to Farm Bill Implementation – What Lies Ahead for Advance Biofuels and Renewable Chemicals?”.

Bayoubuzz.com provides this article only as a news aggregator, NOT as the publisher or as the author. After reading this small portion of the article, please click upon the ORIGINAL SOURCE link above and read the original article. Thank you.


Hover over video bottom right and click full screen for better viewing

latter-blum2

Share Bayoubuzz

Powered By JFBConnect